AGIOS PHARMACEUTICALS, INC. Insider Trading for April 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for April 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2014 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Buy | P | 44.00 | 294,800 | 12,971,200 | 1,003,133 | 708.3 K to 1 M (+41.62 %) |
| Apr 30 2014 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | P | 44.00 | 2,250 | 99,000 | 46,583 | 44.3 K to 46.6 K (+5.08 %) |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 3,000 | 908 | 318,767 | |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | A | 2.34 | 47,727 | 111,681 | 321,767 | |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 45.17 | 3,000 | 135,510 | 209,090 | 212.1 K to 209.1 K (-1.41 %) |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 3,000 | 908 | 212,090 | 209.1 K to 212.1 K (+1.43 %) |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | D | 2.34 | 569 | 1,331 | 144,998 | |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | D | 0.69 | 1,431 | 984 | 145,567 | |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | A | 9.05 | 10,909 | 98,726 | 146,998 | |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | A | 2.34 | 21,818 | 51,054 | 136,089 | |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 45.17 | 2,000 | 90,340 | 0 | 2 K to 0 (-100.00 %) |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 2.34 | 569 | 1,331 | 2,000 | 1.4 K to 2 K (+39.76 %) |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 1,431 | 984 | 1,431 | 0 to 1.4 K |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 2.34 | 54,546 | 127,638 | 817,320 | |
| Apr 08 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 2.34 | 47,727 | 111,681 | 333,317 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.69 | 3,053 | 2,099 | 114,271 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.47 | 947 | 443 | 117,324 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 38.08 | 4,000 | 152,320 | 0 | 4 K to 0 (-100.00 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 3,053 | 2,099 | 4,000 | 947 to 4 K (+322.39 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.47 | 947 | 443 | 947 | 0 to 947 |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 12,000 | 3,630 | 274,040 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 38.08 | 12,000 | 456,960 | 209,090 | 221.1 K to 209.1 K (-5.43 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 12,000 | 3,630 | 221,090 | 209.1 K to 221.1 K (+5.74 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 4,500 | 2,104 | 285,590 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 12,000 | 5,610 | 290,090 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 18,000 | 8,415 | 302,090 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 38.08 | 4,500 | 171,360 | 30,000 | 34.5 K to 30 K (-13.04 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 4,500 | 2,104 | 34,500 | 30 K to 34.5 K (+15.00 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 12,000 | 5,610 | 30,000 | 18 K to 30 K (+66.67 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 18,000 | 8,415 | 18,000 | 0 to 18 K |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Tessier-Lavigne Marc | Director | Buy | P | 18.00 | 55,555 | 999,990 | 101,009 | 45.5 K to 101 K (+122.22 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | P | 18.00 | 8,333 | 149,994 | 44,333 | 36 K to 44.3 K (+23.15 %) |